申请人:GLAXO GROUP LTD
公开号:WO2003080580A2
公开(公告)日:2003-10-02
The present invention relates to quinoline compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 and R2 independently represent hydrogen or C1-6 alkyl or R1 is linked to R2 to form a group (CH2)2, (CH2)3 or (CH2)4; R3, R4 and R5 independently represent hydrogen, halogen, cyano, -CF3, -CF3O, C1-6 alkyl, C1-6 alkoxy, C1-6 alkanoyl or a group -CONR6R7; m represents an integer from 1 to 4, such that when m is an integer greater than 1, two R2 groups may instead be linked to form a group CH2, (CH2)2 or (CH2)3; n represents an integer from 1 to 3; p represents 1 or 2; A represents a group -Ar1 or -Ar2Ar3; Ar1, Ar2 and Ar3 independently represent and aryl group or a heteroaryl group, both of which may be optionally substituted by one or more substituents having pharmacological activity, to processes for their preparation, to compositions containing them and to their use in the treatment of CNS and other disorders.
本发明涉及式(I)的喹啉化合物或其药学上可接受的盐,其中R1和R2独立地表示氢或C1-6烷基,或R1与R2连接形成(CH2)2、(CH2)3或(CH2)4基团;R3、R4和R5独立地表示氢、卤素、氰基、-CF3、-CF3O、C1-6烷基、C1-6烷氧基、C1-6烷酰基或-CONR6R7基团;m表示1到4的整数,当m是大于1的整数时,两个R2基团可以连接形成(CH2)、(CH2)2或(CH2)3基团;n表示1到3的整数;p表示1或2;A表示-Ar1或-Ar2Ar3基团;Ar1、Ar2和Ar3独立地表示芳基或杂环芳基,两者均可以选择性地被一个或多个具有药理活性的取代基所取代,本发明还涉及其制备方法、含有它们的组合物以及它们在治疗中枢神经系统和其他疾病中的应用。